Showing results (1-10 of 510) with videos related to

Sort By:
Pageof 51
Schizophrenia Research|November 22, 2016
Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studiesGiovanni Ostuzzi, Irene Bighelli, Ryuhei So, et al.
BMJ Open|March 16, 2018
Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trialsIrene Bighelli, Georgia Salanti, Cornelia Reitmeir, et al.
The Cochrane Database of Systematic Reviews|April 6, 2018
Antidepressants versus placebo for panic disorder in adultsIrene Bighelli, Mariasole Castellazzi, Andrea Cipriani, et al.
BMJ Open|January 22, 2020
Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidenceIrene Bighelli, Alessandro Rodolico, Gabi Pitschel-Walz, et al.
The Cochrane Database of Systematic Reviews|September 13, 2016
Antidepressants and benzodiazepines for panic disorder in adultsIrene Bighelli, Carlotta Trespidi, Mariasole Castellazzi, et al.
Schizophrenia Bulletin|August 18, 2021
How Efficacious Are Antipsychotic Drugs for Schizophrenia? An Interpretation Based on 13 Effect Size IndicesStefan Leucht, Spyridon Siafis, Rolf R Engel, et al.
The Cochrane Database of Systematic Reviews|March 29, 2019
Benzodiazepines versus placebo for panic disorder in adultsJohanna Breilmann, Francesca Girlanda, Giuseppe Guaiana, et al.
Journal of Psychosomatic Research|May 22, 2010
Assessment of mood: guides for cliniciansToshi A Furukawa
The Lancet. Psychiatry|July 20, 2019
Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysisJohannes Schneider-Thoma, Orestis Efthimiou, Irene Bighelli, et al.
The Cochrane Database of Systematic Reviews|October 1, 2014
Azapirones versus placebo for panic disorder in adultsHissei Imai, Aran Tajika, Peiyao Chen, et al.
Pageof 51